Delivery Order SPE2DB24D2003-SPE2DB24FXGA1
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of LINZESS 145 MCG capsules. The ceiling value of the contract is $3,617.28 and the ultimate completion date is November 17, 2023. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG capsules. The contract has a ceiling value of $1,882.29 and a completion date of September 17, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of LINZESS 145 MCG capsules. The contract has a firm fixed price of $4,196.85 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of pharmaceutical and medical supplies to support military...
This is a $5,539.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 145 MCG capsules to federal government agencies. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG CAPSULE UU 30S medication. The contract has a ceiling value of $1,543.27 and a completion date of November 4, 2024. It is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG Capsules. The contract has a ceiling value of $30,772.20 and is a firm fixed-price contract. The period of performance extends to September 11, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with AmerisourceBergen, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG CAPSULE in 30-count units. The $1,740.98 firm-fixed-price contract has a completion date of July 19, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which serves as the primary vehicle for providing pharmaceutical and medical...
This is a $5,418.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LINZESS 145 MCG capsules to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LINZESS 72 MCG CAPSULE medical products, with a ceiling value of $1,624.42 and a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the supply of 4,565,166,995 units of the prescription drug LINZESS 145 MCG Capsule. The contract has a ceiling value of $2,059.67 and a period of performance ending on July 17, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds several...